← Evidence map

ArticleBritish journal of clinical pharmacology2011

Additional safety risk to exceptionally approved drugs in Europe?

Arna H Arnardottir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 21501215